Navigation Links
Cayenne Medical, Inc. Appoints David B. Springer President & CEO
Date:2/9/2011

SCOTTSDALE, Ariz., Feb. 9, 2011 /PRNewswire/ -- Cayenne Medical, Inc., a private sports medicine device company specializing in the soft tissue reconstruction segment, announced that effective immediately, David B. Springer will succeed James Hart as President and Chief Executive Officer, who has transitioned to Executive Chairman due to health reasons.

Hart, who has led Cayenne Medical as Chairman, President and CEO since the company's inception in 2005, will continue to work with management and the Board in guiding the strategic direction of the company.

"As a founding member, I have a personal commitment and passion for Cayenne and its proven soft-tissue reconstruction technology platform," said James Hart, Executive Chairman, Cayenne Medical.  "I plan to work with David to ensure a smooth transition, and am confident that his medical device leadership experience will be invaluable to the ongoing growth and success of the company, particularly as we continue to see increased surgeon demand for our AperFix® System."

Springer, 46, joins Cayenne with over 20 years executive leadership experience in Healthcare Fortune 500, and emerging, entrepreneurial companies in the medical device industry.  His significant experience includes the successful commercialization of numerous products, improved sales performance and operational strategy implementation.

"I am looking forward to leading Cayenne Medical through its next phase of growth and expansion by capitalizing on its unique technology platform and impressive surgeon adoption momentum," said Springer.  "I see great opportunity to execute on the company's corporate vision to be a leader in the sports medicine market and bring a full line of innovative solutions to customers so they can better serve their patients."

Most recently, Springer served as President & CEO of CHF Solutions, Inc. in Brooklyn Park, MN, where he successfully led the company to profitabi
'/>"/>

SOURCE Cayenne Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
2. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
3. Nonin Medical, Inc. Launches New WristOx2™, Model 3150 in U.S. and Canada
4. Kevin Banion Named CEO of Progressive Medical, Inc.
5. Solta Medical, Inc. Appoints Thomas J. Yorkey, Ph.D. to Vice President of Research & Development
6. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
7. Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
8. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
9. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
10. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
11. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... , Deutschland, October 19, 2014 ... gefragt. Das Problem dabei ist, dass ... mit der Kompetenz zu teilen. Es ... deshalb freuen wir uns umso mehr, dass es ... ihre Gepflogenheiten bei Kühlketten aufzuschreiben - mit einem ...
(Date:10/17/2014)... 2014 With the recent changes in ... come across several challenges in creating and utilizing ... The Medical Affairs Consortium ... providing benchmarking and best practices across critical Medical ... service composed of three stages: 1) member-driven topic ...
(Date:10/17/2014)... -- Hanger, Inc. (NYSE: HGR ) announced today ... for the quarter ended September 30, 2014, on Thursday, ... call to discuss these results is scheduled to begin ... Those wishing to participate should call 1-877-662-6095. A replay ... dialing 1-855-859-2056 and referencing Conference ID # 91880739. ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Early Key Findings from the Medical Affairs Consortium Research 2
... Antibacterial Products aimed at reducing cross contamination ... infections ... Corporation,announced today the SILVER SEAL(TM) family of antibacterial products for,infection ... and Mouse. According to the company, the,SILVER SEAL(TM) Keyboard and ...
... - Once Granted by the European Commission, ATRIPLA Would Represent the, First ... ... Union -, PRINCETON, N.J., FOSTER CITY, Calif. and WHITEHOUSE STATION, N.J., ... GILD ) and Merck & Co., Inc. (NYSE: MRK ),announced ...
Cached Medicine Technology:Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 2Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10
(Date:10/20/2014)... It’s hard to imagine what it’s like to live without ... world, it’s a reality. And while new shoes are considered ... walk barefoot on rocky terrain or sewage-lined streets just to ... , Buckner International's Shoes for Orphan Souls ... to encourage support for Air1 and while also providing new ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Hastings and ... 30 years of service throughout the greater Phoenix area ... legal representation with regard to catastrophic automobile accidents. Statistics ... the country and throughout Arizona. As such, Hastings and ... for legal representation for those who have been injured ...
(Date:10/19/2014)... This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ... late-stage and discontinued projects. , Partial Seizures are ...
(Date:10/19/2014)... SweetDressy.com, a professional company of women’s dresses and ... evening dresses . All the company’s old and ... discount is up to 66 percent off. , ... fashion field. Its dress specialists are striving to make ... of the world. All the company’s items are unique, ...
(Date:10/19/2014)... that causes inflammation in the spinal joints and ... ancient Egyptian royal families. Now a new study ... journal of the American College of Rheumatology (ACR), ... condition called diffuse idiopathic skeletal hyperostosis (DISH) in ... 20th Dynasties. , Ankylosing spondylitis is a ...
Breaking Medicine News(10 mins):Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2
... 2008) Two Mayo Clinic researchers who study the role ... the formation of kidney stones, will lead a symposium on ... symposium will take place April 8 at the Experimental Biology ... smaller than the bacteria, E. coli, but recent advances in ...
... Group And Digital Peach Interactive Group Unite To ... Networks To Improve Women,s Healthcare, NEW YORK, ... company,comprised of multiple specialized and related businesses focused ... today a,unique partnership that will engage, connect and ...
... Leading Maker of Rugged Computers Donates GoBook(R) XR-1 Notebooks to ... Support ... General Dynamics,Itronix, an industry leading maker of rugged notebook ... Expedition,2008: Fighting Malaria on the "River of Life." The XR-1 ...
... from overweight, high blood pressure and metabolic disturbances ... is the result of a study with almost ... of the Deutsches rzteblatt International (Dtsch Arztebl Int ... The so-called metabolic syndrome describes a typical constellation ...
... finds having autistic child shrinks family income by 14% , , ... additional light on two different aspects of autism: One tried ... while the other looked at the financial toll that having ... were expected to be published in the April issue of ...
... 2008 MedCath,Corporation (Nasdaq: MDTH ) announced ... percent interest in a joint venture known as ... venture provides cardiac,catheterization lab services to Yuma Regional ... Management and Service Agreement with,the Hospital., The ...
Cached Medicine News:Health News:Symposium to explore role nanoparticles may play in disease 2Health News:Kinetix Creates Innovative Online Model to Engage and Educate Healthcare Professionals 2Health News:General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa 2Health News:General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa 3Health News:Very Premature Babies Show Raised Risk for Autism 2Health News:Very Premature Babies Show Raised Risk for Autism 3Health News:MedCath Announces Acquisition of Ownership in Arizona Cath Lab 2
Selute Picotip Atrial-J steroid eluting passive fixation lead...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: